Abstract:Objective: To investigate the effect of reversing multi-drug resistance and killing tumor cells of mesoporous silica nanoparticles (MSNP) co-delivery system, and to confirm whether combined application of Doxovubicin (DOX) and MDR1 shRNA can exert a synergistic antitumor effect. Methods:Firstly, mesoporous silica nanoparticles were prepared by sol-gel method under room temperature and coated by cationic polymerpolyethylenimine (PEI) on the surface to stay positive charge, which could facilitate its combination with negatively charged MDR1 shRNA in the next step. With the absorption of DOX, an antitumor drug, the drug and gene co-delivery system was then formed. In vitro, drug loading was <br> evaluated by UV-Vis spectrophotometer;antitumor drugs were co-cultured respectively with oral squamous cells carcinoma cells lines KB and resistant cell lines KBV. Then MTT assay was conducted to measure the half maximal inhibitory concentration (IC50); Fluorescence microscope and flow cytometry instrument were used to measure the transfection efficiency of the co-delivery system; Real-Time PCR technique was applied to detect the expression of MDR1 gene;AnnexinV-FITC/7-AAD double staining by flow cytometry was conducted to detect cell apoptosis. Results: The MSNP appeared to have a high dispersibility and homogeneous size by particle size analyzer and transmission electron microscopy (TEM). The formed nanoparticles have a diameter distribution of 100-200 nm, and the surface mesoporous diameter is 3-5 nm. IC50 (KB-DOX) was 182.9 ng/mL, and IC50 (KBV-DOX) was 9 233.5 ng/mL by ultraviolet spectrophotometer. The resistance index of KBV was 50.483 871. The transfection efficiency is 6.73% measured by fluorescence microscope and flow cytometry . The Real-Time PCR test indicated that MDR1 mRNA expression in the co-delivery system decreased dramatically, compared with co-delivery nanoparticles. The results of AnnexinV-FITC/7-AAD double staining showed that the cell apoptosis rates were 12.74% and 10.08% for drug-loaded and gene-loaded nanoparticles respectively, while cell apoptosis rate increased to 25.68%for co-delivery nanoparticles. Conclusion:The results demonstrate that comparing with the pure medicine or genome, the mesoporous silica nanoparticles co-delivery system can effectively reverse multi-drug resistance of tumor and inhibited the growth of tumor dramatically. At the same time, DOX and the MDR1 shRNA can exert synergistic antitumor effect when applied in combination.

Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy.

Reversing of Multidrug Resistance Breast Cancer by Co-Delivery of P-gp Sirna and Doxorubicin Via Folic Acid-Modified Core-Shell Nanomicelles

Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail

Multifunctional Molecular Beacon Micelles for Intracellular Mrna Imaging and Synergistic Therapy in Multidrug-Resistant Cancer Cells

A targeted nanoplatform co-delivery of pooled siRNA and doxorubicin for reversing of multidrug resistance in breast cancer

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.

Increasing The Cytotoxicity Of Doxorubicin In Breast Cancer Mcf-7 Cells With Multidrug Resistance Using A Mesoporous Silica Nanoparticle Drug Delivery System

A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance

Codelivery of an Optimal Drug/sirna Combination Using Mesoporous Silica Nanoparticles to Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo.

Co-delivery of Doxorubicin and MDR1 shRNA by Mesoporous Silica Nanoparticles to Overcome Drug Resistance in vitro

Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA

Mesoporous Silica Nanoparticles Loading Doxorubicin Reverse Multidrug Resistance: Performance And Mechanism

Multifunctional Molecular Beacons-Modified Gold Nanoparticle As a Nanocarrier for Synergistic Inhibition and in Situ Imaging of Drug-Resistant-Related Mrnas in Living Cells

In Vitro Studies of Phospholipid-Modified PAMAM-siMDR1 Complexes for the Reversal of Multidrug Resistance in Human Breast Cancer Cells.

Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppression

Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with PD-L1 blockade in reversing multidrug resistance

Multi-functionalized Nano-conjugate for Combating Multidrug Resistant Breast Cancer Via Starvation-Assisted Chemotherapy.

Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk

Functionalized Graphene Oxide Mediated Adriamycin Delivery And Mir-21 Gene Silencing To Overcome Tumor Multidrug Resistance In Vitro

Co-delivery of Doxorubicin and P-gp Sirna into Human Breast Cancer Cells by Functionalized PLGA Nanobubbles and Ultrasound Imaging in Vitro.